InflaRx NV (IFRX)
1.41
+0.04
(+2.92%)
USD |
NASDAQ |
May 01, 16:00
1.36
-0.05
(-3.55%)
After-Hours: 20:00
InflaRx Total Liabilities (Quarterly): 19.48M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 19.48M |
| September 30, 2023 | 12.17M |
| June 30, 2023 | 9.04M |
| March 31, 2023 | 8.431M |
| December 31, 2022 | 15.07M |
| September 30, 2022 | 11.48M |
| June 30, 2022 | 13.06M |
| March 31, 2022 | 22.28M |
| December 31, 2021 | 22.48M |
| September 30, 2021 | 16.41M |
| June 30, 2021 | 13.58M |
| March 31, 2021 | 9.846M |
| December 31, 2020 | 12.73M |
| September 30, 2020 | 13.65M |
| Date | Value |
|---|---|
| June 30, 2020 | 14.34M |
| March 31, 2020 | 13.23M |
| December 31, 2019 | 16.16M |
| September 30, 2019 | 20.10M |
| June 30, 2019 | 15.98M |
| March 31, 2019 | 10.10M |
| December 31, 2018 | 8.949M |
| September 30, 2018 | 7.052M |
| June 30, 2018 | 4.416M |
| March 31, 2018 | 5.177M |
| December 31, 2017 | 5.739M |
| September 30, 2017 | 70.87M |
| June 30, 2017 | 67.77M |
| December 31, 2016 | 58.36M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
8.431M
Minimum
Mar 2023
22.48M
Maximum
Dec 2021
14.71M
Average
13.65M
Median
Sep 2020
Total Liabilities (Quarterly) Benchmarks
| Affimed NV | 43.50M |
| MorphoSys AG | 2.186B |
| BioNTech SE | 3.051B |
| Immatics NV | 314.91M |
| CureVac NV | 299.90M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 132.88M |
| Shareholders Equity (Quarterly) | 113.39M |
| Current Ratio | 6.499 |